Min-Seong Kim

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules

H. Kim, K. Peck, Y. C. Kim, 2022, Frontiers in Cellular and Infection Microbiology.

Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals

Su-Hwan Kim, J. Noh, J. Yoon, 2022, Journal of Infection.